Dear readers of ADxS.org, please forgive the disruption.

ADxS.org needs about $19740 in 2023. In 2022 we received donations from third parties of about $ 13870. Unfortunately, 99.8% of our readers do not donate. If everyone who reads this request makes a small contribution, our fundraising campaign for 2023 would be over after a few days. This donation request is displayed 12,000 times a week, but only 140 people donate. If you find ADxS.org useful, please take a minute and support ADxS.org with your donation. Thank you!

Since 01.06.2021 ADxS.org is supported by the non-profit ADxS e.V..

$0 of $19740 - as of 2023-01-03
0%
Header Image
Trazodone for ADHD

Sitemap

Trazodone for ADHD

Trazodone is antidepressant (SARI) that is sometimes helpful in ADHD as a sleep aid.
More on this at Krause.1

  • Phenylpiperazine
  • Blockade of 5HT2A receptors leads to dopamine elevation in the striatum via glutamate reduction and enhances serotonergic neurotransmission via 5-HT1A receptors
  • Low-dose (up to 50 mg): 5HT2A receptor antagonist
  • Higher doses are also serotonergic and antihistaminergic. Low doses (up to 50 mg) are not serotonergic.
  • Sleep-inducing in ADHD when taken in low doses (25 to 100 mg)
  • Half-life 5 to 9 hours
  • No impairment of sexual functions
  • No increase in body weight
  • Strongly inhibits α1-receptors
  • Weakly inhibits α2- and H1-receptors
  • Attenuating effect on tremor
  • Not contraindicated in glaucoma and prostate disorders
  • No extrapyramidal effect (no motor restlessness)
  • No potentiation of adrenergic transmission
  • No anticholinergic activity, therefore does not have the typical side effects of tricyclic antidepressants
  • Cross-effects
    • Should not be combined with MAO inhibitors or (especially if high-dose) with serotonergic medications
Diese Seite wurde am 08.08.2022 zuletzt aktualisiert.